EXAI Competitors & Alternatives
Compare with similar stocks in the same industry
EXAI
Main StockSupply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 6/10
Drug Discovery Biotech
Drug Design
Top Competitors
7 stocks in| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$2.72
-6.37%
|
$2.23B | - | 49 | Compare |
|
SDGR
Schrodinger, Inc. Common Stock
|
$25.66
-6.21%
|
$1.56B | - | 38 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$1.88
|
$951.83M | - | 48 | Compare |
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$16.47
-4.63%
|
$917.23M | - | 53 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.58
+1.40%
|
$468.01M | - | 48 | Compare |
|
VERV
VERV
|
- | - | - | - | Compare |
More EXAI Analysis
Data updated: Nov 17, 2026 | Industry: (SIC None)
7 stocks in this industry